Narayana Hrudayalaya Limited
NSE: NH BSE: NH
Prev Close
1743.4
Open Price
1749.8
Volume
187,623
Today Low / High
1730.4 / 1758.9
52 WK Low / High
1171 / 1871.6
Range
1,663 - 1,838
Prev Close
1743.2
Open Price
1751.9
Volume
3,949
Today Low / High
1731.4 / 1758.6
52 WK Low / High
1171.35 / 1872.85
Range
1,666 - 1,841
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 1750.7 (target range: 1,663 - 1,838), reflecting a change of 7.3 (0.41872%). On the BSE, it is listed at 1753.2 (target range: 1,666 - 1,841), showing a change of 10 (0.57366%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.
Narayana Hrudayalaya Limited Graph
Narayana Hrudayalaya Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Narayana Hrudayalaya Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 1,750.70, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
Scenario | Price | Target | Range |
---|---|---|---|
Bullish Scenario | 1,753.20 | 1,770.73 | 1,593.66 - 1,947.81 |
1,788.26 | 1,430.61 - 2,145.92 | ||
1,805.80 | 1,264.06 - 2,347.53 | ||
Bearish Scenario | 1,753.20 | 1,735.67 | 1,562.10 - 1,909.23 |
1,718.14 | 1,374.51 - 2,061.76 | ||
1,700.60 | 1,190.42 - 2,210.79 |
Overview of Narayana Hrudayalaya Limited
ISIN
INE410P01011
Industry
Medical - Care Facilities
Vol.Avg
573,646
Market Cap
357,774,802,700
Last Dividend
4
Official Website
IPO Date
2016-01-06
DCF Diff
-1,793.96
DCF
3,545
Financial Ratios Every Investor Needs
Stock Dividend of NH
Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
---|---|---|---|---|---|---|
2025-08-01 | August 01, 25 | 4.5 | 4.5 | 2025-08-01 | 2025-09-28 | |
2024-08-02 | August 02, 24 | 4 | 4 | 2024-08-02 | 2024-09-29 | |
2023-07-06 | July 06, 23 | 2.5 | 2.5 | 2023-07-07 | 2023-09-03 | |
2022-08-22 | August 22, 22 | 1 | 1 | 2022-08-23 | 2022-09-29 | |
2020-03-11 | March 11, 20 | 1 | 1 | 2020-03-12 | 2020-03-18 | 2020-02-27 |
Annual Financial Income Report
Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
---|---|---|---|---|---|---|---|---|---|---|---|
2024-03-31 | 5,003.70 Cr | 3,780.08 Cr | 1,223.62 Cr | 0.2445 | 2.98 Cr | 161.50 Cr | 942.02 Cr | 789.26 Cr | 38.86 | 1,242.52 Cr | 0.1577 |
2023-03-31 | 4,524.77 Cr | 2,661.27 Cr | 1,863.49 Cr | 0.4118 | 2.62 Cr | 167.26 Cr | 767.30 Cr | 606.25 Cr | 29.85 | 1,045.52 Cr | 0.1340 |
2022-03-31 | 3,701.32 Cr | 2,021.68 Cr | 1,679.64 Cr | 0.4538 | 2.56 Cr | 112.15 Cr | 481.22 Cr | 341.93 Cr | 16.85 | 697.16 Cr | 0.0924 |
2021-03-31 | 2,582.35 Cr | 1,563.61 Cr | 1,018.73 Cr | 0.3945 | 2.39 Cr | 106.47 Cr | 6.87 Cr | -14.30 Cr | -0.70 | 216.07 Cr | -0.0055 |
2020-03-31 | 3,127.81 Cr | 1,777.82 Cr | 1,349.99 Cr | 0.4316 | 0.00 Cr | 122.55 Cr | 247.90 Cr | 118.92 Cr | 5.86 | 444.02 Cr | 0.0380 |
Annual Financials Balance Sheet
Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-03-31 | 263.83 Cr | 5,624.58 Cr | 2,739.49 Cr | 2,883.6810 Cr | 1,626.69 Cr | 1,362.87 Cr | 109.95 Cr | 3,247.81 Cr | 63.61 Cr | 132.20 Cr | -779.04 Cr | 1,110.3820 Cr |
2023-03-31 | 154.76 Cr | 4,162.09 Cr | 2,029.67 Cr | 2,131.3820 Cr | 884.17 Cr | 729.41 Cr | 71.57 Cr | 2,312.55 Cr | 96.48 Cr | 127.97 Cr | 10.57 Cr | 987.2680 Cr |
2022-03-31 | 157.50 Cr | 3,129.71 Cr | 1,640.35 Cr | 1,488.6370 Cr | 723.42 Cr | 565.93 Cr | 59.38 Cr | 1,938.23 Cr | 172.23 Cr | 122.19 Cr | 2.46 Cr | 779.4200 Cr |
2021-03-31 | 110.73 Cr | 2,770.02 Cr | 1,649.20 Cr | 1,120.2780 Cr | 825.64 Cr | 714.91 Cr | 47.84 Cr | 1,862.29 Cr | 138.60 Cr | 123.27 Cr | 11.30 Cr | 703.2370 Cr |
2020-03-31 | 102.69 Cr | 2,891.06 Cr | 1,754.56 Cr | 1,135.9640 Cr | 952.21 Cr | 849.52 Cr | 60.24 Cr | 1,983.57 Cr | 87.73 Cr | 129.76 Cr | 17.89 Cr | 600.2590 Cr |
Annual Financials Cash Flow Statement
Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
---|---|---|---|---|---|---|---|---|---|---|---|
2024-03-31 | 1,066.6000 Cr | -1,457.9410 Cr | 488.4510 Cr | 95.9930 Cr | 97.1490 Cr | 241.7430 Cr | -970.6070 Cr | 789.6240 Cr | 612.0700 Cr | -50.7670 Cr | -38.3770 Cr |
2023-03-31 | 1,084.5590 Cr | -1,174.1010 Cr | 87.7410 Cr | 562.5160 Cr | -3.9340 Cr | 144.5940 Cr | -522.0430 Cr | 606.5660 Cr | 151.2330 Cr | -20.2960 Cr | -11.6980 Cr |
2022-03-31 | 485.0170 Cr | -266.9140 Cr | -158.9480 Cr | 234.3340 Cr | 59.0210 Cr | 148.5280 Cr | -250.6830 Cr | 342.1200 Cr | -122.7840 Cr | 0.0000 Cr | -11.5370 Cr |
2021-03-31 | 309.0530 Cr | -112.9860 Cr | -198.4310 Cr | 238.9520 Cr | -2.3370 Cr | 89.5070 Cr | -70.1010 Cr | -14.2940 Cr | -102.0650 Cr | 0.0000 Cr | 12.4020 Cr |
2020-03-31 | 443.3450 Cr | -188.5440 Cr | -246.9450 Cr | 327.4590 Cr | 7.4910 Cr | 91.8440 Cr | -115.8860 Cr | 119.0520 Cr | -147.2020 Cr | -48.9710 Cr | 18.2550 Cr |
Quarterly Financial Income Report
Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
---|---|---|---|---|---|---|---|---|---|
2024-12-31 | 1,366.68 Cr | 512.93 Cr | 853.75 Cr | 0.6247 | 237.04 Cr | 192.94 Cr | 9.50 | 325.37 Cr | 0.1412 |
2024-09-30 | 1,400.01 Cr | 892.72 Cr | 507.28 Cr | 0.3623 | 243.30 Cr | 198.63 Cr | 9.78 | 332.03 Cr | 0.1419 |
2024-06-30 | 1,340.95 Cr | 862.05 Cr | 478.90 Cr | 0.3571 | 242.21 Cr | 201.38 Cr | 9.92 | 327.36 Cr | 0.1502 |
2024-03-31 | 1,275.94 Cr | 507.76 Cr | 768.18 Cr | 0.6020 | 269.51 Cr | 190.71 Cr | 9.39 | 318.44 Cr | 0.1495 |
2023-12-31 | 1,203.64 Cr | 462.69 Cr | 740.95 Cr | 0.6156 | 233.64 Cr | 188.02 Cr | 9.26 | 296.83 Cr | 0.1562 |
Quarterly Financials Balance Sheet
Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
---|---|---|---|---|---|---|---|---|---|
2024-09-30 | 245.67 Cr | 939.99 Cr | 1,185.66 Cr | 542.59 Cr | 120.00 Cr | 2,047.00 Cr | 3,557.42 Cr | 6,242.86 Cr | 3,035.52 Cr |
2024-06-30 | -1,256.15 Cr | 2,512.30 Cr | 1,256.15 Cr | 0.00 Cr | 0.00 Cr | 1,256.15 Cr | 0.00 Cr | 0.00 Cr | -2,885.09 Cr |
2024-03-31 | 263.83 Cr | 1,082.23 Cr | 1,346.05 Cr | 502.56 Cr | 109.95 Cr | 1,946.06 Cr | 2,914.41 Cr | 5,624.58 Cr | 2,739.49 Cr |
2023-12-31 | -871.90 Cr | 1,743.81 Cr | 871.90 Cr | 0.00 Cr | 0.00 Cr | 871.90 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
2023-09-30 | 111.80 Cr | 843.50 Cr | 955.30 Cr | 555.93 Cr | 74.62 Cr | 1,675.58 Cr | 2,560.17 Cr | 4,786.84 Cr | 2,283.88 Cr |
Quarterly Financials Cash Flow Statement
Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
---|---|---|---|---|---|---|---|---|---|
2024-06-30 | 201.38 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
2024-03-31 | 190.71 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
2023-12-31 | 188.02 Cr | 126.37 Cr | 0.00 Cr | 0.00 Cr | 126.37 Cr | 238.17 Cr | 111.80 Cr | 0.00 Cr | 126.37 Cr |
2023-09-30 | 226.58 Cr | 110.55 Cr | 0.00 Cr | 0.00 Cr | 110.55 Cr | 111.80 Cr | 1.25 Cr | 0.00 Cr | 110.55 Cr |
2023-06-30 | 183.95 Cr | 117.78 Cr | 0.00 Cr | 0.00 Cr | 117.78 Cr | 272.54 Cr | 154.76 Cr | 0.00 Cr | 117.78 Cr |
Splits History
Date | Label | Split Ratio |
---|---|---|
No split history data available. |
Similar Stocks: Medical - Care Facilities
Company Name | Symbol | Price | Market Cap | Volume |
---|---|---|---|---|
Max Healthcare Institute Limited | MAXHEALTH | ₹1,168.20 | ₹1,135,662,125,400.00 | ₹1,026,473.00 |
Apollo Hospitals Enterprise Limited | APOLLOHOSP | ₹6,942.50 | ₹998,227,362,500.00 | ₹269,395.00 |
Fortis Healthcare Limited | FORTIS | ₹763.30 | ₹576,259,441,400.00 | ₹2,851,039.00 |
Narayana Hrudayalaya Limited | NH | ₹1,750.70 | ₹357,774,802,700.00 | ₹187,623.00 |
Global Health Limited | MEDANTA | ₹1,216.10 | ₹326,629,100,657.00 | ₹121,345.00 |
Aster DM Healthcare Limited | ASTERDM | ₹578.25 | ₹288,843,392,250.00 | ₹413,067.00 |
Krishna Institute of Medical Sciences Limited | KIMS | ₹660.40 | ₹264,251,795,600.00 | ₹224,266.00 |
Rainbow Children's Medicare Limited | RAINBOW | ₹1,413.70 | ₹143,563,601,534.00 | ₹113,702.00 |
HealthCare Global Enterprises Limited | HCG | ₹552.50 | ₹77,026,787,500.00 | ₹172,479.00 |
Yatharth Hospital & Trauma Care Services Limited | YATHARTH | ₹539.80 | ₹52,012,080,829.00 | ₹824,366.00 |
Indraprastha Medical Corporation Limited | INDRAMEDCO | ₹430.10 | ₹39,428,557,300.00 | ₹81,771.00 |
Artemis Medicare Services Limited | ARTEMISMED | ₹267.45 | ₹37,148,805,000.00 | ₹71,736.00 |
Kovai Medical Center and Hospital Limited | KOVAI | ₹2,581.00 | ₹35,290,787,300.00 | ₹5,780.00 |
Key Executives
Gender: male
Year Born:
Gender: male
Year Born: 1966
Gender: male
Year Born:
Gender: male
Year Born:
Gender: male
Year Born:
Gender: Not Specified
Year Born: 1953
Gender: Not Specified
Year Born: 1967
Gender: male
Year Born: 1984
Gender: female
Year Born:
Gender: male
Year Born: 1974
FAQs about Narayana Hrudayalaya Limited
The CEO is Dr. Emmanuel Rupert.
The current price is ₹1,750.70.
The range is ₹1171-1871.6.
The market capitalization is ₹35,777.48 crores.
The dividend yield is 0.23%.
The P/E ratio is 45.37.
The company operates in the Healthcare sector.
Overview of Narayana Hrudayalaya Limited (ISIN: INE410P01011) is a leading Medical - Care Facilities in India. With a market capitalization of ₹35,777.48 crores and an average daily volume of 573,646 shares, it operates in the Medical - Care Facilities. The company last declared a dividend of ₹4.